GUGGENHEIM CAPITAL LLC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$1,661,000
+403.3%
22,082
+79.4%
0.01%
+550.0%
Q1 2022$330,000
-41.4%
12,307
+4.3%
0.00%
-33.3%
Q4 2021$563,000
-21.5%
11,803
+9.4%
0.00%
-25.0%
Q3 2021$717,000
-1.0%
10,788
+16.2%
0.00%0.0%
Q2 2021$724,000
-5.1%
9,283
+15.1%
0.00%
-20.0%
Q1 2021$763,000
+48.4%
8,066
+91.1%
0.01%
+66.7%
Q4 2020$514,0004,2200.00%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,737,297$176,802,0006.75%
MPM BioImpact LLC 308,686$19,938,0005.30%
Burrage Capital Management LLC 77,172$4,985,0003.49%
Orbimed Advisors 2,745,327$177,321,0002.50%
Parkman Healthcare Partners LLC 110,318$7,125,0002.01%
SECTORAL ASSET MANAGEMENT INC 284,486$18,375,0001.69%
First Light Asset Management, LLC 192,829$12,455,0001.45%
Asymmetry Capital Management, L.P. 22,608$1,460,0001.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,000$2,236,0000.74%
Prosight Management, LP 25,602$1,654,0000.71%
View complete list of TURNING POINT THERAPEUTICS I shareholders